Publications
268
Citations
6,622
Est. group size
—
Recurring co-author estimate
Active years
27
Publishing since 2000
Matthew Zirwas is a dermatology researcher and clinician focused on inflammatory and allergic skin conditions such as atopic dermatitis (eczema), seborrheic dermatitis, hand eczema, and alopecia areata. Much of the work involves clinical trials testing the safety and effectiveness of new topical and systemic drug treatments, as well as studies on patient experiences, disease burden, and treatment patterns. The research is largely industry- and clinically-oriented, aimed at informing dermatology practice and drug development.
Publication output has fluctuated over the past decade with a notable peak in 2023, but has remained fairly active overall, averaging about 11 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- What Dermatology Residents Need to Know About Joining Group Practices
Cutis · 2026
- Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study
Journal of the American Academy of Dermatology · 2025
- Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
Journal of the European Academy of Dermatology and Venereology · 2025
- Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis
Journal of Drugs in Dermatology · 2025
- Patient and healthcare provider perspectives on treatment patterns and patient satisfaction of seborrheic dermatitis in the United States
Journal of Dermatological Treatment · 2025
- Flexible Dosing of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Initial Results From the Real-World–Simulating Expanded Access Protocol Study, JADE REAL
SKIN The Journal of Cutaneous Medicine · 2025
- Protocol to Help Neurologists Manage Subcutaneous Apomorphine Therapy Skin Nodules: Expert Roundtable Recommendations (P7-5.023)
Neurology · 2025
- Burden of Atopic Dermatitis in Patients Initiating Systemic Therapies in the United States
Advances in Therapy · 2025
- LB1143 Is upadacitinib cardioprotective? An assessment of MACE and VTE risk in patients with atopic dermatitis
Journal of Investigative Dermatology · 2025
- LB1144 Treatment-free disease control after tralokinumab in patients with moderate-to-severe atopic dermatitis
Journal of Investigative Dermatology · 2025
- 63397 Systemic treatment and healthcare resource utilization in US patients with atopic dermatitis across ethnic groups: a retrospective analysis of the US Medicaid database (2017-2022)
Journal of the American Academy of Dermatology · 2025
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Journal of the American Academy of Dermatology · 2024
- Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial
Journal of the American Academy of Dermatology · 2024
- 564 - Conjunctivitis adverse events in dupilumab clinical trials
British Journal of Dermatology · 2024
- Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey
Dermatology and Therapy · 2024
- Journal of the American Academy of Dermatology×28
- SKIN The Journal of Cutaneous Medicine×20
- Dermatitis×19
- PubMed×14
- British Journal of Dermatology×8
- Karissa Libson
Medicine · The Ohio State University
- Leon Kircik
Medicine · Indiana University
- Paulo Gomes
Medicine · Purdue University West Lafayette
- David Rosmarin
Medicine · Indiana University
- Brian T. Cheng
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile